The Flowr Corporation FLWPF

FLWPF Company Overview

The Flowr Corporation, formerly traded in the U.S. over-the-counter market under ticker FLWPF and in Canada under TSX Venture Exchange listings, was a Canadian cannabis company focused on the cultivation, processing, and sale of premium cannabis products for medical and adult-use markets. The company operated primarily in the legal cannabis industry, with activities spanning cultivation, extraction, branded consumer products, and international cannabis distribution. Its core revenue drivers historically included wholesale cannabis sales, branded dried flower products, and cannabis-derived products distributed through regulated provincial channels and international medical cannabis partnerships.

The company positioned itself around premium cultivation methods, emphasizing small-batch production, controlled-environment agriculture, and high-quality genetics. A major strategic differentiator was its cultivation platform located in Kelowna, British Columbia, designed around high-efficiency greenhouse technology. Flowr evolved through acquisitions, licensing agreements, and strategic investments during the rapid expansion of the Canadian cannabis sector following legalization in Canada in 2018. Public filings and restructuring disclosures later indicated significant financial distress, creditor protection proceedings, and operational reductions. Data regarding ongoing active operations after restructuring is inconclusive based on available public sources.